EW

爱德华生命科学
NYSE

实时行情|Nasdaq Last Sale

227.46
-0.34
-0.15%
盘后: 227.46 0 0.00% 16:42 10/18 EDT
开盘
227.36
昨收
227.80
最高
229.67
最低
227.29
成交量
125.61万
成交额
--
52周最高
230.19
52周最低
136.44
市值
473.05亿
市盈率(TTM)
63.06
分时
5日
1月
3月
1年
5年

分析师评级

22位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

EW 新闻

  • The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict
  • Benzinga.17小时前
  • Cerner (CERN) to Report Q3 Earnings: What's in the Offing?
  • Zacks.2天前
  • What's in the Offing for Baxter's (BAX) Earnings in Q3?
  • Zacks.2天前
  • What's in Store for Varian Medical (VAR) in Q4 Earnings?
  • Zacks.3天前

更多

所属板块

先进医疗设备和技术
+0.51%
医疗设备和用品
+0.23%

热门股票

名称
价格
涨跌幅

EW 简况

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products are categorized into three areas: Transcatheter Heart Valve Therapy, Surgical Heart Valve Therapy and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. It is developing products, such as the Edwards SAPIEN 3 Ultra System and Edwards SAPIEN XT transcatheter heart valve, among others. Its Transcatheter Heart Valve Therapy and Surgical Heart Valve Therapy products are manufactured in the United States, Singapore and Switzerland. Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.
展开

Webull提供Edwards Lifesciences Corp的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。